Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Pharmacologic injection treatment of comitant strabismus

Full text
Debert, Iara [1, 2, 3, 4] ; Miller, Joel M. [2, 3] ; Danh, Kenneth K. [2, 3] ; Scott, Alan B. [2, 3]
Total Authors: 4
[1] Univ Sao Paulo, Hosp Clin, Sao Paulo - Brazil
[2] Strabismus Res Fdn, Mill Valley, CA - USA
[3] Eidactics, Med Arts Bldg, Suite 210, 2000 Van Ness Ave, San Francisco, CA 94109 - USA
[4] Inst Strabos, Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: JOURNAL OF AAPOS; v. 20, n. 2, p. 106-111, APR 2016.
Web of Science Citations: 7

PURPOSE To report the magnitude and stability of corrections in comitant horizontal strabismus achieved by injecting bupivacaine (BPX, optionally with epinephrine) and botulinum A toxin (BTXA) into extraocular muscles of alert adult subjects with electromyographic (EMG) guidance. METHODS A total of 55 adults with comitant horizontal strabismus participated in a prospective observational clinical series. Of these, 29 previously had undergone 1 or more unsuccessful strabismus surgeries; 4 had undergone other orbital surgeries. Thirty-one patients with esodeviations received BPX injections in a lateral rectus muscle, some with BTXA in the medial rectus; 24 patients with exodeviations received BPX in a medial rectus muscle, some with BTXA in the lateral rectus muscle. A second treatment (BPX, BTXA, or both) was administered to 27 patients who had residual strabismus after the first treatment. Five patients required additional injections. Clinical alignment was measured at 6 months and yearly thereafter through 5 years' follow-up, with mean follow-up of 28 months. A successful outcome was defined as residual deviation <= 10(Delta). RESULTS On average, presenting misalignment of 23.8(Delta) (13.4 degrees) was reduced at 28 months by 16.0(Delta) (9.1 degrees), with successful outcomes in 56% of patients. Of patients with initial misalignments <= 25(Delta), 66% had successful outcomes, with corrections averaging 13.2(Delta) (7.5 degrees); of patients with larger misalignments, 40% had successful outcomes, with corrections averaging 20.9(Delta) (11.8 degrees). Corrected alignments were stable over follow-ups as long as 5 years. CONCLUSIONS Injection treatments resulted in stable, clinically significant corrections in comitant horizontal strabismus. Injection provides a low-cost alternative to incisional strabismus surgery, particularly where it is desirable to minimize surgical anesthesia and avoid extraocular scarring. (AU)

FAPESP's process: 14/06807-6 - Strabismus treatment in children: a model that allows bupivacaine injection of extraocular muscles
Grantee:Iara Debert
Support type: Scholarships abroad - Research